| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 60.1 | 83.9 | 128.3 | 131.8 | 94.2 | −28.5% | |
| Cost of revenue | 48.7 | 55.4 | 85.2 | 91.4 | 58.0 | −36.6% | |
| Gross profit | 11.4 | 28.5 | 43.1 | 40.4 | 36.2 | −10.3% | |
| Research & development | 29.3 | 17.5 | 12.1 | 13.9 | 11.8 | −15.3% | |
| Operating expenses | 82.2 | 86.0 | 70.0 | 66.6 | 50.4 | −24.3% | |
| Operating income | (70.8) | (57.5) | (26.9) | (26.2) | (14.2) | +45.9% | |
| Interest expense | — | 0.3 | 0.1 | 0.7 | 0.5 | −21.9% | |
| Interest income | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Pre-tax income | (70.7) | (58.6) | (26.7) | (22.1) | (13.2) | +40.2% | |
| Income tax | (1.3) | 0.2 | 0.1 | 0.1 | 0.1 | +113.3% | |
| Net income | (68.8) | (56.8) | (25.2) | (21.5) | (13.2) | +38.5% | |
| EPS, basic (per share) | (1.46) | (1.21) | (19.80) | (4.91) | (5.47) | −11.5% | |
| EPS, diluted (per share) | (1.46) | (1.21) | (19.80) | (4.91) | (5.47) | −11.5% | |
| EBITDA | (64.8) | (52.1) | (22.0) | (22.5) | (10.5) | +53.2% | |
| Depreciation & amortization | 6.0 | 5.4 | 4.9 | 3.7 | 3.6 | −1.3% | |
| Weighted average shares (shares) | 47,072,492 | 47,072,492 | 47,072,492 | 47,072,492 | 47,072,492 | +0.0% | |
| Weighted average diluted shares (shares) | 47,072,492 | 47,072,492 | 47,072,492 | 47,072,492 | 47,072,492 | +0.0% | |
| Gross margin | 19.0% | 34.0% | 33.6% | 30.7% | 38.5% | +7.8 pts | |
| Operating margin | −117.9% | −68.6% | −21.0% | −19.9% | −15.1% | +4.8 pts | |
| Net margin | −114.5% | −67.6% | −19.6% | −16.3% | −14.0% | +2.3 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
